Apr 24, 2026 | Knowledge Hub
We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Anticonvulsant drug level testing is available for the following: Perampanel (Fycompa) Oxcarbazepine (Trileptal) (including...
Apr 23, 2026 | Knowledge Hub
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). The data is dependent on submission of samples by clinicians and therefore may not be...
Mar 16, 2026 | Knowledge Hub
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during February 2026 (epidemiological weeks 6-9). The data is dependent on submission of samples by clinicians and therefore may not be...
Feb 17, 2026 | Knowledge Hub
Infective endocarditis (IE) is a globally prevalent condition associated with high morbidity and mortality (1,2). Although historically rare, the annual estimated incidence has increased to 13.8 cases per 100 000 patients, attributable to an increased incidence of...
Feb 17, 2026 | Knowledge Hub
Clostridioides difficile infection (CDI) remains a leading cause of healthcare-associated diarrhoea and antibiotic-associated colitis. C. difficile produces 2 types of toxins; toxins A and B (encoded by TcdA & TcdB genes, respectively), which are virulence factors...
